Teva settlement prevents Lupin from launching its Austedo generic until 2033
Teva settlement prevents Lupin from launching its Austedo generic until [...]
With FDA approval, Supernus’ Qelbree is the first nonstimulant ADHD med for adults in 2 decades
With FDA approval, Supernus’ Qelbree is the first nonstimulant ADHD [...]
Emergent mourns passing of founder and former CEO El-Hibri just one month after his retirement
Emergent mourns passing of founder and former CEO El-Hibri just [...]
AbbVie’s red-hot Rinvoq scores fourth FDA approval in five months
AbbVie’s red-hot Rinvoq scores fourth FDA approval in five months [...]
Pfizer loses top vaccine scientist Jansen who led drive for COVID-19 shot, searches for successor
Pfizer loses top vaccine scientist Jansen who led drive for [...]
Novo’s Wegovy supply rebound on track for later this year as demand stays strong
Novo’s Wegovy supply rebound on track for later this year [...]
Amid legal tumult, J&J shareholders reject proposal to end talc sales worldwide
Amid legal tumult, J&J shareholders reject proposal to end talc [...]
Amid Humira’s decline, AbbVie’s Rinvoq falls short of analyst forecasts and Skyrizi delivers
Amid Humira’s decline, AbbVie’s Rinvoq falls short of analyst forecasts [...]
AstraZeneca’s Farxiga hits $1B quarterly mark, but flagship oncology and China units lag
AstraZeneca’s Farxiga hits $1B quarterly mark, but flagship oncology and [...]
As superstar Revlimid fades faster than expected, BMS trims $600M from its 2022 sales projection
As superstar Revlimid fades faster than expected, BMS trims $600M [...]